ANI PHARMACEUTICALS INC
Reported by THE BANK OF NEW YORK MELLON CORPORATION
Reported 0 shares, down 250,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
18 managers reported ANI PHARMACEUTICALS INC for Q4 2019.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| EVOKE WEALTH LLC | New | 3 | +3 | < 0.01% | $185 | 1 qtr |
| CITADEL ADVISORS LLC | Reduced | 0 | -16,403,000 | 0 | $0 | 8 qtrs |
| CONCOURSE FINANCIAL GROUP SECURITIES INC | Unchanged | 0 | 0 | 0 | $0 | 6 qtrs |
| Weiss Asset Management LP | Unchanged | 0 | 0 | 0 | $0 | 2 qtrs |
| Citigroup Inc | Reduced | 0 | -20,719,000 | 0 | $0 | 14 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION This report | Reduced | 0 | -250,000 | 0 | $0 | 20 qtrs |
| WELLS FARGO & COMPANY MN | Reduced | 0 | -23,000 | 0 | $0 | 7 qtrs |
| COMMONWEALTH EQUITY SERVICES LLC | Reduced | 0 | -29,000 | 0 | $0 | 9 qtrs |
| MANGROVE PARTNERS | Reduced | 0 | -18,779,000 | 0 | $0 | 12 qtrs |
| Verdence Capital Advisors LLC | Reduced | 0 | -13,000 | 0 | $0 | 9 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2019
- Filed
- February 14, 2020
- Filing type
- 13F-HR
- Position type
- NOTE
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.